Cancer vaccine prevents deadly melanoma from returning or spreading in landmark trial

Aug-20-2026, 20:49:47 GMT–FOX News

Moderna and Merck's personalized mRNA cancer vaccine reduced melanoma recurrence and metastasis in a Phase 3 trial. The companies plan to seek FDA approval.

artificial intelligence, melanoma, press release, (13 more...)

FOX News

Aug-20-2026, 20:49:47 GMT

News Web Page

Add feedback

Country:
- North America > United States (1.00)

Genre:
- Press Release (0.69)
- Research Report > New Finding (0.49)

Industry:
- Health & Medicine > Therapeutic Area
  - Oncology (1.00)
- Government > Regional Government
  - North America Government > United States Government > FDA (1.00)

Technology:
- Information Technology
  - Communications > Social Media (0.97)
  - Artificial Intelligence (0.96)